Lycopene, atherosclerosis, and coronary heart disease

Experimental Biology and Medicine

Volumn 227, Issue 10, 2002, Pages 900-907

  Rissanen, Tiina ^a,b,c   Voutilainen, Sari ^a,b,c   Nyyssönen, Kristiina ^a,b,c   Salonen, Jukka T ^a,b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Department of Public Health and General Practice ^*  (Finland)

^c Inner Savo Health Centre   (Finland)

Author keywords

Artherosclerosis carotid arteries; ASAP study; Carotenoids; Coronary event; KIHD study; Lycopene; Nutrition; Stroke

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CAROTENOID; LYCOPENE;

ADULT; AGED; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD LEVEL; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; FRUIT; HEALTH STATUS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; PUBLIC HEALTH; RISK FACTOR; STROKE; TOMATO; VEGETABLE;

LYCOPERSICON ESCULENTUM;

EID: 0036847624     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222701010     Document Type: Conference Paper

References (39)

1. Kardinaal AF, Kok FJ. Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van't Veer P, Huttunen JK, Martin-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study. Lancet 342:1379-1384, 1993.
2. Gaziano JM, Manson JE, Branch LG, Colditz GA, Willett WC, Buring JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 5:255-260, 1995.
3. Price JE, Fowkes FG. Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence. Eur Heart J 18:719-727, 1997.
4. Kristenson M, Zieden B, Kucinskiene Z, Elinder LS, Bergdahl B, Elwing B, Alearavicius A, Razinkoviene L, Caltauskash H, Olsson AG. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross sectional study of men aged 50. Br Med J 314:629-633, 1997.
5. Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, Kardinaal AF, Ringstad J, Thamm M, Masev V, Riemersma R, Martin-Moreno JM, Huttunen JK, Kok FJ. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 146:618-626, 1997.
6. van Poppel G. Epidemiological evidence for β-carotene in prevention of cancer and cardiovascular disease. Eur J Clin Nutr 50(Suppl 3):S57-S61, 1996.
7. Clinton SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev 56:35-51, 1998.
8. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274:532-538, 1989.
9. Suganuma H, Inakuma T. Protective effect of dietary tomato against endothelial dysfunction in hypercholesterolemic mice. Biosci Biotechnol Biochem 63:78-82, 1999.
10. Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids 33:981-984, 1998.
11. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssödnen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992.
12. Salonen JT, Nyyssönen K, Salonen R, Porkkala-Sarataho E, Tuomainen TP, Diczfalusy U, Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95:840-845, 1997.
13. Rissanen T, Voutilainen S, Nyyssonen K, Salonen R, Salonen JT. Low plasma lycopene concentration is associated with increased intimamedia thickness of the carotid artery wall. Arterioscler Thromb Vasc Biol 20:2677-2681, 2000.
14. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Sivenius J, Salonen R, Kaplan GA, Salonen JT. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: The Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 85:743-754, 2001.
15. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20:46-50, 1988.
16. Salonen JT, Nyyssönen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen T-P, Valkonen V-P, Ristonmaa U, Poulsen HE. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248:377-386. 2000.
17. Porkkala-Sarataho E, Nyyssönen K, Salonen JT. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men. Atherosclerosis 124:83-94, 1996.
18. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 34:377-381, 1988.
19. Willett WC. Implications of Total Energy Intake for Epidemiologic Analyses. New York: Oxford University Press, pp273-301, 1998.
20. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 90:1154-1161, 1994.
21. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87(3 Suppl):1156-1165, 1993.
22. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22, 1999.
23. Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators: Atherosclerosis Risk in Communities. Arterioscler Thromb Vasc Biol 17:1171-1177, 1997.
24. Kritchevsky SB, Tell GS, Shimakawa T, Dennis B, Li R, Kohlmeier L, Steere E, Heiss G. Provitamin A carotenoid intake and carotid artery plaques: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr 68:726-733, 1998.
25. Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JC. Serum carotenoids and atherosclerosis: The Rotterdam Study. Atherosclerosis 148:49-56, 2000.
26. Bonithon-Kopp C, Coudray C, Berr C, Touboul PJ, Feve JM, Favier A, Ducimetiere P. Combined effects of lipid peroxidation and antioxidant. status on carotid atherosclerosis in a population aged 59-71 years: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 65:121-127, 1997.
27. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31:2301-2306, 2000.
28. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willet WC. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130:963-970, 1999.
29. Witztum JL, Horkko S. The role of oxidized LDL in atherogenesis: Immunological response and anti-phospholipid antibodies. Ann N Y Acad Sci 811:88-96, 1997.
30. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408-416, 1997.
31. Stahl W, Sies H. Lycopene: A biologically important carotenoid for humans? Arch Biochem Biophys 336:1-9, 1996.
32. Rao AV, Agarwal S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr Res 18:713-721, 1998.
33. Rao AV, Agarwal S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19:563-569, 2000.
34. Martin KR, Wu D, Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis 150:265-274, 2000.
35. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 99:2383-2388, 1999.
36. D'Odorico A, Martines D, Kiechl S, Egger G, Oberhollenzer F, Bonvicini P, Sturniolo GC, Naccurato R, Willeit J. High plasma levels of α- and β-carotene are associated with a lower risk of atherosclerosis: Results from the Bruneck study. Atherosclerosis 153:231-239, 2000.
37. Järvinen R. Carotenoids retinoids, tocopherols and tocotrienols in the diet; the Finnish Mobile Clinic Health Examination Survey. Int J Vitam Nutr Res 65:24-30, 1995.
38. Granado F. Olmedilla B. Blanco I, Rojas-Hidalgo E. Major fruit and vegetable contributors to the main serum carotenoids in the Spanish diet. Eur J Clin Nutr 50:246-250, 1996.
39. Forman MR, Lanza E, Yong LC, Holden JM, Graubard BI, Beecher GR, Meltiz M, Brown ED, Smith JC. The correlation between two dietary assessments of carotenoid intake and plasma carotenoid concentrations: Application of a carotenoid food-composition database. Am J Clin Nutr 58:519-524, 1993.